📢Our new paper is out in @ScienceTM 📢
Diabetic retinopathy (DR) is a leading cause of blindness. Patients show vascular changes in their retinas long before vision starts to deteriorate.
What triggers these early defects? Could targeting them prevent vision loss? 🧵
📢Our new paper is out in @ScienceTM 📢
Diabetic retinopathy (DR) is a leading cause of blindness. Patients show vascular changes in their retinas long before vision starts to deteriorate.
What triggers these early defects? Could targeting them prevent vision loss? 🧵
12 covers have been selected for the 9th Annual Blood Cover Art Contest. Vote now! Voting closes February 7, 2025 and the winner will be announced February 13, 2025. ow.ly/pyBB50UFKm2
🚨New paper alert!🚨@LabWhiteford and I are excited to share our latest research published in @BrJPharmacol describing the development and pre-clinical testing 🧪of a novel peptide for neovascular (or wet) age-related macular degeneration (nvAMD).
(Quick 🧵below)
Our review article on the tumor microenvironment in B-cell lymphoma, part of a series collection, is available in Blood. Full access link authors.elsevier.com/a/1ioEY…
@BloodJournal
If you are keen to work as a POSTDOC with us in London on translational cancer research and tumour microenvironment signalling- please apply....5 days left!! ucl.ac.uk/work-at-ucl/search…
We are pleased to report our work revealing how ibrutinib enhances anti-cancer T cells, with cover image captured by Despoina! Thanks to group and all our amazing collaborators and funders. (1/2) #Immunotherapy#CLL#lymphoma@NIHFunding @BloodJournal
twtr.to/dlO1N
Online now:
Read the In The Spotlight Commentary— Structural vulnerabilities in DLBCL for enhanced treatment strategies, by @theLundLab discussing a recent @jclinicalinvest paper, from @RamsayLab.
bit.ly/3NUR1yi
Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma: buff.ly/3NypGS0
Adam Yuh Lin & @ligordon highlight FRCs as a potential target to optimize immunotherapy for treatment of lymphoma; #Commentary
Related: buff.ly/43d2z5p
Targeting the tumour environment could improve immunotherapy responses for lymphoma patients
Research from @RamsayLab shows how this cancer reprogrammes cells key to our immune system
Read more below ⤵️ #lymphoma#immunesystemkcl.ac.uk/news/targeting-the…
Very proud of my first TEM image 😍 - well, I only contributed the sample and the coloring skills, the image was taken by TEM master @BioBurgoyne.
Retinal capillary: Pericyte in green, EC in blue, BM in yellow and RBC in red.
#SciComm#eye#microscopy#STEM#DiabeticRetinopathy
Big shoutout to Despoina Papazoglou from @RamsayLab.
@UkCll forum travel grant winner, presenting elegant work of in vitro bi-specific therapy in #CLL successfully engaging T-cell response.